Literature DB >> 21224412

RA-inducible gene-I induction augments STAT1 activation to inhibit leukemia cell proliferation.

Lin-Jia Jiang1, Nan-Nan Zhang, Fei Ding, Xian-Yang Li, Lei Chen, Hong-Xin Zhang, Wu Zhang, Sai-Juan Chen, Zhu-Gang Wang, Jun-Min Li, Zhu Chen, Jiang Zhu.   

Abstract

RA-inducible gene I (RIG-I/DDX58) has been shown to activate IFN-β promoter stimulator 1 (IPS-1) on recognizing cytoplasmic viral RNAs. It is unclear how RIG-I functions within the IFN and/or RA signaling process in acute myeloid leukemia (AML) cells, however, where obvious RIG-I induction is observed. Here, we show that the RIG-I induction functionally contributes to IFN-α plus RA-triggered growth inhibition of AML cells. Interestingly, although RIG-I induction itself is under the regulation of STAT1, a major IFN intracellular signal mediator, under circumstances in which it does not stimulate IPS-1, it conversely augments STAT1 activation to induce IFN-stimulatory gene expression and inhibit leukemia cell proliferation. Thus, our results unveil a previously undescribed RIG-I activity in regulating the cellular proliferation of leukemia cells via STAT1, which is independent of its classic role of sensing viral invasion to trigger type I IFN transcription.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21224412      PMCID: PMC3033283          DOI: 10.1073/pnas.1019059108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

Review 1.  Regulation of JAK-STAT signalling in the immune system.

Authors:  Ke Shuai; Bin Liu
Journal:  Nat Rev Immunol       Date:  2003-11       Impact factor: 53.106

Review 2.  Stats: transcriptional control and biological impact.

Authors:  David E Levy; J E Darnell
Journal:  Nat Rev Mol Cell Biol       Date:  2002-09       Impact factor: 94.444

3.  Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signaling.

Authors:  D A Frank; S Mahajan; J Ritz
Journal:  Nat Med       Date:  1999-04       Impact factor: 53.440

4.  Krüppel-like factor 4 (gut-enriched Krüppel-like factor) inhibits cell proliferation by blocking G1/S progression of the cell cycle.

Authors:  X Chen; D C Johns; D E Geiman; E Marban; D T Dang; G Hamlin; R Sun; V W Yang
Journal:  J Biol Chem       Date:  2001-06-04       Impact factor: 5.157

5.  Chronic myeloid leukemia cells resistant to interferon-alpha lack STAT1 expression.

Authors:  S Landolfo; A Guarini; L Riera; M Gariglio; G Gribaudo; A Cignetti; I Cordone; E Montefusco; F Mandelli; R Foa
Journal:  Hematol J       Date:  2000

6.  Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL.

Authors:  L Altucci; A Rossin; W Raffelsberger; A Reitmair; C Chomienne; H Gronemeyer
Journal:  Nat Med       Date:  2001-06       Impact factor: 53.440

7.  Gene expression networks underlying retinoic acid-induced differentiation of acute promyelocytic leukemia cells.

Authors:  T X Liu; J W Zhang; J Tao; R B Zhang; Q H Zhang; C J Zhao; J H Tong; M Lanotte; S Waxman; S J Chen; M Mao; G X Hu; L Zhu; Z Chen
Journal:  Blood       Date:  2000-08-15       Impact factor: 22.113

8.  PKCepsilon is a permissive link in integrin-dependent IFN-gamma signalling that facilitates JAK phosphorylation of STAT1.

Authors:  Johanna Ivaska; Lisardo Bosca; Peter J Parker
Journal:  Nat Cell Biol       Date:  2003-04       Impact factor: 28.824

Review 9.  The role of signal transducer and activator of transcription factors in leukemogenesis.

Authors:  David W Sternberg; D Gary Gilliland
Journal:  J Clin Oncol       Date:  2004-01-15       Impact factor: 44.544

10.  Ser727/Tyr701-phosphorylated Stat1 is required for the regulation of c-Myc, cyclins, and p27Kip1 associated with ATRA-induced G0/G1 arrest of U-937 cells.

Authors:  Anna Dimberg; Inger Karlberg; Kenneth Nilsson; Fredrik Oberg
Journal:  Blood       Date:  2003-03-13       Impact factor: 22.113

View more
  37 in total

1.  DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts.

Authors:  David Roulois; Helen Loo Yau; Rajat Singhania; Yadong Wang; Arnavaz Danesh; Shu Yi Shen; Han Han; Gangning Liang; Peter A Jones; Trevor J Pugh; Catherine O'Brien; Daniel D De Carvalho
Journal:  Cell       Date:  2015-08-27       Impact factor: 41.582

2.  Exome-wide analyses identify low-frequency variant in CYP26B1 and additional coding variants associated with esophageal squamous cell carcinoma.

Authors:  Jiang Chang; Rong Zhong; Jianbo Tian; Jiaoyuan Li; Kan Zhai; Juntao Ke; Jiao Lou; Wei Chen; Beibei Zhu; Na Shen; Yi Zhang; Ying Zhu; Yajie Gong; Yang Yang; Danyi Zou; Xiating Peng; Zhi Zhang; Xuemei Zhang; Kun Huang; Tangchun Wu; Chen Wu; Xiaoping Miao; Dongxin Lin
Journal:  Nat Genet       Date:  2018-01-29       Impact factor: 38.330

Review 3.  Targeting pattern recognition receptors in cancer immunotherapy.

Authors:  Nadège Goutagny; Yann Estornes; Uzma Hasan; Serge Lebecque; Christophe Caux
Journal:  Target Oncol       Date:  2012-03-08       Impact factor: 4.493

4.  Double-stranded RNA induces biphasic STAT1 phosphorylation by both type I interferon (IFN)-dependent and type I IFN-independent pathways.

Authors:  Junichi Dempoya; Tomoh Matsumiya; Tadaatsu Imaizumi; Ryo Hayakari; Fei Xing; Hidemi Yoshida; Ken Okumura; Kei Satoh
Journal:  J Virol       Date:  2012-09-12       Impact factor: 5.103

5.  iTRAQ based quantitative proteomics approach validated the role of calcyclin binding protein (CacyBP) in promoting colorectal cancer metastasis.

Authors:  Dipanjana Ghosh; Zhihan Li; Xing Fei Tan; Teck Kwang Lim; Yubin Mao; Qingsong Lin
Journal:  Mol Cell Proteomics       Date:  2013-03-29       Impact factor: 5.911

6.  Fascin1 suppresses RIG-I-like receptor signaling and interferon-β production by associating with IκB kinase ϵ (IKKϵ) in colon cancer.

Authors:  Tomio Matsumura; Shigeaki Hida; Masato Kitazawa; Chifumi Fujii; Akira Kobayashi; Michiko Takeoka; Shun-Ichiro Taniguchi; Shin-Ichi Miyagawa
Journal:  J Biol Chem       Date:  2018-03-01       Impact factor: 5.157

7.  miR-155 promotes FLT3-ITD-induced myeloproliferative disease through inhibition of the interferon response.

Authors:  Jared A Wallace; Dominique A Kagele; Anna M Eiring; Carissa N Kim; Ruozhen Hu; Marah C Runtsch; Margaret Alexander; Thomas B Huffaker; Soh-Hyun Lee; Ami B Patel; Timothy L Mosbruger; Warren P Voth; Dinesh S Rao; Rodney R Miles; June L Round; Michael W Deininger; Ryan M O'Connell
Journal:  Blood       Date:  2017-04-21       Impact factor: 22.113

8.  IL-1Ra protects hematopoietic cells from chemotoxicity through p53-induced quiescence.

Authors:  Hao Ye; Lan Qian; Shunying Zhu; Shaorong Deng; Xia Wang; Jiang Zhu; Gerald L Chan; Yan Yu; Wei Han
Journal:  FASEB J       Date:  2019-08-05       Impact factor: 5.191

9.  Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy.

Authors:  Edit Porpaczy; Sabrina Tripolt; Andrea Hoelbl-Kovacic; Bettina Gisslinger; Zsuzsanna Bago-Horvath; Emilio Casanova-Hevia; Emmanuelle Clappier; Thomas Decker; Sabine Fajmann; Daniela A Fux; Georg Greiner; Sinan Gueltekin; Gerwin Heller; Harald Herkner; Gregor Hoermann; Jean-Jacques Kiladjian; Thomas Kolbe; Christoph Kornauth; Maria-Theresa Krauth; Robert Kralovics; Leonhard Muellauer; Mathias Mueller; Michaela Prchal-Murphy; Eva Maria Putz; Emmanuel Raffoux; Ana-Iris Schiefer; Klaus Schmetterer; Christine Schneckenleithner; Ingrid Simonitsch-Klupp; Cathrin Skrabs; Wolfgang R Sperr; Philipp Bernhard Staber; Birgit Strobl; Peter Valent; Ulrich Jaeger; Heinz Gisslinger; Veronika Sexl
Journal:  Blood       Date:  2018-06-14       Impact factor: 22.113

10.  The DHX33 RNA helicase senses cytosolic RNA and activates the NLRP3 inflammasome.

Authors:  Hiroki Mitoma; Shino Hanabuchi; Taeil Kim; Musheng Bao; Zhiqiang Zhang; Naoshi Sugimoto; Yong-Jun Liu
Journal:  Immunity       Date:  2013-07-18       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.